BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12465076)

  • 1. An imaging study of parkinsonism among African-Caribbean and Indian London communities.
    Hu MT; Chaudhuri KR; Jarosz J; Yaguez L; Brooks DJ
    Mov Disord; 2002 Nov; 17(6):1321-8. PubMed ID: 12465076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
    Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK.
    Chaudhuri KR; Hu MT; Brooks DJ
    Mov Disord; 2000 Jan; 15(1):18-23. PubMed ID: 10634237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
    Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
    Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical application value of brain
    Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
    [No Abstract]   [Full Text] [Related]  

  • 15. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
    Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
    Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
    Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
    Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.